Cargando…

Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain

With reactive astrogliosis being established as one of the hallmarks of Alzheimer’s disease (AD), there is high interest in developing novel positron emission tomography (PET) tracers to detect early astrocyte reactivity. BU99008, a novel astrocytic PET ligand targeting imidazoline-2 binding sites (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Amit, Koistinen, Niina A., Malarte, Mona-Lisa, Nennesmo, Inger, Ingelsson, Martin, Ghetti, Bernardino, Lemoine, Laetitia, Nordberg, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758481/ https://www.ncbi.nlm.nih.gov/pubmed/33888872 http://dx.doi.org/10.1038/s41380-021-01101-5

Ejemplares similares

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
por: Malarte, Mona-Lisa, et al.
Publicado: (2020)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

First evaluation of PET-based human biodistribution and radiation dosimetry of (11)C-BU99008, a tracer for imaging the imidazoline(2) binding site
por: Venkataraman, Ashwin V., et al.
Publicado: (2018)

Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue
por: Lemoine, Laetitia, et al.
Publicado: (2015)

Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography
por: Lemoine, Laetitia, et al.
Publicado: (2017)

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer’s disease variants: AβPParc and PSEN1DE9
por: Lemoine, Laetitia, et al.
Publicado: (2020)

Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective
por: Fontana, Igor C., et al.
Publicado: (2023)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
por: Lemoine, Laetitia, et al.
Publicado: (2017)

Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with (11)C-BU99008 PET
por: Mohamed, Mohamed A, et al.
Publicado: (2022)

Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using (11)C-BU99008 PET and its relationship with amyloid load
por: Calsolaro, Valeria, et al.
Publicado: (2021)

Relationship between astrocyte reactivity, using novel (11)C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
por: Livingston, Nicholas R., et al.
Publicado: (2022)

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging
por: Murugan, N. Arul, et al.
Publicado: (2019)

Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer’s Tauopathy
por: Murugan, N. Arul, et al.
Publicado: (2021)

In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue
por: Ni, Ruiqing, et al.
Publicado: (2021)

(3)H-Deprenyl and (3)H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain
por: Marutle, Amelia, et al.
Publicado: (2013)

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
por: Kadir, Ahmadul, et al.
Publicado: (2011)

Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
por: Li, Junhao, et al.
Publicado: (2023)

Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils
por: Zhou, Yang, et al.
Publicado: (2021)

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
por: Schöll, Michael, et al.
Publicado: (2015)

Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer’s Disease
por: Gonzalez-Rodriguez, Melania, et al.
Publicado: (2021)

Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022)

Assessment of Tau Pathology as Measured by (18)F-THK5317 and (18)F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease
por: Colato, Elisa, et al.
Publicado: (2021)

Atypical astroglial pTDP‐43 pathology in astroglial predominant tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2021)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Physiology of Astroglial Excitability
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
por: Bischof, Gérard N, et al.
Publicado: (2021)

Astroglial Induction of in vivo Angiogenesis
por: Suárez, I., et al.
Publicado: (1994)

Astroglial Connexins in Neurodegenerative Diseases
por: Huang, Xiaomin, et al.
Publicado: (2021)

Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain
por: Chiotis, Konstantinos, et al.
Publicado: (2018)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

Mutation screening of patients with Alzheimer disease identifies APP locus duplication in a Swedish patient
por: Thonberg, Håkan, et al.
Publicado: (2011)

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development
por: Nordberg, Agneta
Publicado: (2011)

APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer’s disease mice
por: Stephen, T. L., et al.
Publicado: (2022)

Astroglial networking contributes to neurometabolic coupling
por: Escartin, Carole, et al.
Publicado: (2013)

Hemichannels: new roles in astroglial function
por: Orellana, Juan A., et al.
Publicado: (2014)

Ammonia Affects Astroglial Proliferation in Culture
por: Bodega, Guillermo, et al.
Publicado: (2015)

RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
por: Smith, Jayden A., et al.
Publicado: (2017)

Astroglial Glutamate Signaling and Uptake in the Hippocampus
por: Rose, Christine R., et al.
Publicado: (2018)

Tau PET imaging in neurodegenerative tauopathies—still a challenge
por: Leuzy, Antoine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5fopdn3po54r2geg82btc959ep